Log in

Relevant bibliographies by topics / Anti diabetic drugs

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Anti diabetic drugs'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti diabetic drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti diabetic drugs"

1

Ulfa, Ridha, Syarifah NYRS Assegaf, and Mistika Zakia. "PEDULI PENYAKIT TIDAK MENULAR DENGAN SKRINING KESEHATAN, BEDAH BUKU DAN PENYULUHAN PENGGUNAAN OBAT ANTI DIABETIK, OBAT HIPERURISEMIA DAN OBAT DISLIPIDEMIA YANG RASIONAL." Medical Dedication (medic) : Jurnal Pengabdian kepada Masyarakat FKIK UNJA 5, no. 1 (2022): 396–402. http://dx.doi.org/10.22437/medicaldedication.v5i1.18681.

Full text

Abstract:

Abstract Concerned for non-communicable diseases by health screening, book review and counseling on the rational use of anti-diabetic drugs, hyperuricemia drugs and dyslipidemia drugs. The purpose of this community service is to increase public knowledge about the dangers of Non-Communicable Diseases (NCD), including cardiovascular disease, diabetes mellitus, dyslipidemia, and hyperuricemia. As well as increasing public awareness about the rational use of anti-diabetic drugs, hyperuricemia drugs and dyslipidemia drugs. The methods of this activity are health checks, blood tests, counseli

APA, Harvard, Vancouver, ISO, and other styles

2

Nanda, Oryza Dwi, Bambang Wiryanto, and Erwin Astha Triyono. "Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus." Amerta Nutrition 2, no. 4 (2018): 340. http://dx.doi.org/10.20473/amnt.v2i4.2018.340-348.

Full text

Abstract:

Background: Blood glucose level controlling is the important thing for diabetes mellitus treatment. Diabetics patients need to understand the factors which influence blood glucose level such as the compliance of anti-diabetic drug.Objective: Determine the relationship and the risk of between oral anti-diabetic drug consumption adherence and blood glucose level regulation for diabetes mellitus female patients.Method: Case control study design with purposive sampling technique, in order to obtain 26 research samples which consist of two groups, they are case group (unregulated blood glucose) whi

APA, Harvard, Vancouver, ISO, and other styles

3

Walia, Smily, J. S. Dua, and D. N. Prasad. "Herbal Drugs with Anti-Diabetic Potential." Journal of Drug Delivery and Therapeutics 11, no. 6 (2021): 248–56. http://dx.doi.org/10.22270/jddt.v11i6.5051.

Full text

Abstract:

Diabetes mellitus (DM), also known as insulin-dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM), is a common and serious metabolic condition that affects people all over the world. Traditional herbal plants have been utilized to treat diabetes mellitus all throughout the world. Several herbs have been found to treat and control diabetes among numerous medicines and poly herbal plants; they also have no adverse effects. Diabetes mellitus is a horrible disease that affects people all over the world and is becoming a serious danger to humanity's health. Thus,

APA, Harvard, Vancouver, ISO, and other styles

4

Sasikumar, Amithkumar, and Sheetal S. "Bruns–Garland syndrome precipitated by anti-tuberculous therapy in a patient with type 2 diabetes mellitus." Nepal Journal of Neuroscience 19, no. 1 (2022): 66–67. http://dx.doi.org/10.3126/njn.v19i1.40952.

Full text

Abstract:

India has a high prevalence of tuberculosis as well as diabetes mellitus, and both contribute to a major disease burden. Diabetes mellitus increases the risk of tuberculosis. Patients with diabetes are more prone to develop cavitary lesions than non-diabetics. Tuberculosis can worsen the glycemic status of an individual and anti-tuberculous drugs like Rifampicin can interact with oral anti-diabetic drugs, further worsening the glycemic control. This can result in complications related to diabetes, like diabetic amyotrophy. We hereby report the case of a 69-year-old gentleman with diabetes mell

APA, Harvard, Vancouver, ISO, and other styles

5

Shaha, Kartick Chanda, Sharmin Jahan, Md Ziaur Rahman Mamun, Md Shafiqur Rahman, Farjana Ahmed, and Bhagyashree Karmokar Jyoti. "Prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at a private Medical College Hospital in Mymensingh." Journal of Dhaka National Medical College & Hospital 23, no. 1 (2017): 29–32. https://doi.org/10.3329/jdnmch.v23i1.78063.

Full text

Abstract:

Background: The right choice of anti-diabetic drugs among type 2 diabetic patients carries a vital role. Objective: The aim of the present study was to evaluate the prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at tertiary level teaching hospital in Mymensingh. Methods: A descriptive, cross sectional study was conducted from July 2015 to June 2016 among patients attending at Medicine Outpatient Department of the Community Based Medical College Hospital. Data were collected through the reviewing of the prescriptions and interviewing of the patients. The collected da

APA, Harvard, Vancouver, ISO, and other styles

6

Siddhi, Nigade* Dinesh Ingole Arundhati Kore Jagruti Shelar. "Review On Anti-Diabetic Drug and Treatment." International Journal of Pharmaceutical Sciences 3, no. 6 (2025): 185–95. https://doi.org/10.5281/zenodo.15574490.

Full text

Abstract:

Diabetes is the third leading cause of death in the United States, and is one of the world's major diseases. Diabetes is a metabolic disorder which is mainly characterized by hyperglycemia and arises from defects in insulin action or both. Approximately 2% of the population in India suffer from diabetes. Anti-diabetic drugs lower the levels of sugar in the blood. Most anti-diabetic drugs are administered by mouth. There are different types of anti-diabetic drugs and their selection depends on a number of factors. Treatments include the agents which increase the amount of insulin produced by th

APA, Harvard, Vancouver, ISO, and other styles

7

Singh, Ved Prakash. "An Overview on Anti Diabetic Drugs and Development." Science & Technology Journal 4, no. 2 (2016): 113–23. http://dx.doi.org/10.22232/stj.2016.04.02.05.

Full text

Abstract:

Diabetes mellitus is one of the world’s major diseases and is the third leading cause of death in the United States after heart disease and cancer. In the India, about 2–6% population suffer from diabetes or related complication. Anti-diabetic drugs treat diabetes mellitus by lowering glucose levels in the blood. Mostly anti-diabetic drugs are administered orally except the insulin, exenatide, and pramlintide. There are different types of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, and many other factors. Treatments include t

APA, Harvard, Vancouver, ISO, and other styles

8

Devkota, HP, A. Adhikari-Devkota, S. Yahara, and P. Basnet. "Anti-oxidative Activity of Nepalese Traditional Anti-diabetic Medicines." Nepal Journal of Science and Technology 14, no. 2 (2014): 151–54. http://dx.doi.org/10.3126/njst.v14i2.10429.

Full text

Abstract:

Chronic overproduction of free radicals in human body has a role in numerous disease states including diabetes. Proper use of antioxidants may help in the prevention and/or treatment of diabetes. For the management of diabetes, a combination of herbal drugs is being practiced traditionally in Nepal. These herbal medicines might have a good correlation to anti-oxidative properties. Anti-oxidative property was evaluated with the methanolic extracts of nineteen common traditional anti-diabetic medicines by 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Among the evaluated herbal

APA, Harvard, Vancouver, ISO, and other styles

9

Kapur, Ajita, Harmeet Singh Rehan, Lalit Kumar Gupta, and Madhur Yadav. "Pattern of anti-diabetic drugs prescribed for type 2 diabetes mellitus patients in a tertiary care hospital of India: an observational study." International Journal of Basic & Clinical Pharmacology 8, no. 7 (2019): 1657. http://dx.doi.org/10.18203/2319-2003.ijbcp20192667.

Full text

Abstract:

Background: Type 2 diabetes mellitus (T2DM) is a leading cause of significant morbidity and mortality in developing countries. Evaluation of anti-diabetic drug use pattern guides the healthcare professionals to identify early signals of irrational prescribing and to plan interventions to optimize the benefits of pharmacotherapy.Methods: Observational descriptive study was conducted on 500 prescriptions of T2DM patients collected from Outpatient department of a tertiary care hospital. Prescriptions were analysed for type, number, generic/brand names, fixed dose combinations (FDCs) of anti-diabe

APA, Harvard, Vancouver, ISO, and other styles

10

Galstyan, Gagik R., Ekaterina A. Shestakova, and Igor A. Sklyanik. "Obesity and type 2 diabetes: can we find a compromised treatment solution?" Diabetes mellitus 20, no. 4 (2017): 270–78. http://dx.doi.org/10.14341/dm8726.

Full text

Abstract:

Type 2 diabetes and obesity are two enormous epidemic diseases of the 21stcentury. Because obesity is a primary risk factor for type 2 diabetes development, patients with diabetes are frequently obese. This comorbidity makes it challenging for these patients to not only compensate diabetes but also bring their weight back to normal. Several anti-diabetic drugs cause weight gain, which augments insulin resistance, and thus demands anti-diabetic treatment intensification. For the treatment, it is crucial to find an anti-diabetic treatment drug that is efficient but does not cause weight gain. In

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Anti diabetic drugs"

1

Hoa, Nguyen Khanh. "Assessment of anti-diabetic effect of Vietnamese herbal drugs /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-585-2/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lennox, Rachael. "Actions of anti-diabetic drugs on hippocampal dependent cognitive function in obesity and type 2 diabetes." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667766.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Li, Xiaoxiao. "Ranolazine: a Potential Anti-diabetic Drug." Thesis, Virginia Tech, 2012. http://hdl.handle.net/10919/19202.

Full text

Abstract:

Diabetes is a life-long chronic disease that affects more than 24 million Americans. Loss of pancreatic beta-cell mass and function is central to the development of both type 1 (T1D) and type 2 diabetes (T2D). Therefore, preservation or regeneration of functional beta-cell mass is one of the essential strategies to treat diabetes [1]. In my study, I tested if ranolazine, a synthetic compound, has potential to prevent or treat diabetes. Diabetes were induced in mice by giving multiple low-doses of streptozotocin (STZ). Ranolazine was given twice daily via an oral gavage (20 mg/kg) for 5 weeks.

APA, Harvard, Vancouver, ISO, and other styles

4

Hamrén, Bengt. "Safety and Efficacy Modelling in Anti-Diabetic Drug Development." Doctoral thesis, Uppsala University, Division of Pharmacokinetics and Drug Therapy, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8648.

Full text

Abstract:

<p>A central aim in drug development is to ensure that the new drug is efficacious and safe in the intended patient population.</p><p>Mathematical models describing the pharmacokinetic-pharmacodynamic (PK-PD) properties of a drug are valuable to increase the knowledge about drug effects and disease and can be used to inform decisions. The aim of this thesis was to develop mechanism-based PK-PD-disease models for important safety and efficacy biomarkers used in anti-diabetic drug development. </p><p>Population PK, PK-PD and disease models were developed, based on data from clinical studies in s

APA, Harvard, Vancouver, ISO, and other styles

5

VanderMeulen, Heather. "Potential anti-inflammatory properties of the diabetic drug metformin." Thesis, McGill University, 2014. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=123091.

Full text

Abstract:

Recent studies have unveiled an anti-inflammatory property of the type 2 diabetes drug, metformin. This has been demonstrated by a decreased severity of endotoxin-induced uveitis in mice. Metformin is also shown to reduce airway remodeling and inflammation in murine models of chronic asthma. While the exact mechanism by which metformin exhibits these effects has yet to be elucidated, the biguanide drug appears to interfere with pro-inflammatory NFkB signaling. We wished to examine whether this phenomenon could be replicated in vivo in various mouse models involving both acute and chronic infla

APA, Harvard, Vancouver, ISO, and other styles

6

Ou, Peimian. "Possible mechanisms for oxidative damage in diabetes mellitus and of some anti-diabetes drugs." Thesis, University College London (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Craythorne, Natalie Louise. "Nanoparticles as potential drug delivery systems for anti-diabetic peptide therapeutics." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.650084.

Full text

Abstract:

Exenatide is a potent glucagon-like peptide-1 receptor agonist used in clinical practice for the management of type 2 diabetes. Exenatide is administered subcutaneously twice daily, or once weekly in the form of poly (Iactide-coglycolide) PLGA microspheres. This study investigated the benefit of using encapsulated nanoparticulate exenatide as an intraperitoneal and oral treatment compared to native peptide. To optomise the encapsulation process and determine its suitability to other peptide or protein formulations, ovalbumin and glucose-dependent insulinotrophic polypeptide (GIP) were used. Th

APA, Harvard, Vancouver, ISO, and other styles

8

Algire, Carolyn. "Impact of the anti-diabetic drug metformin on tumor growth «in vivo»." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103469.

Full text

Abstract:

The prevalence of obesity is rapidly increasing in affluent countries and in many urban areas of the developing world. Epidemiologic studies have associated obesity with increased burden of many cancer types but the mechanisms by which obesity induces transformation or promotes neoplastic growth remain to be fully elucidated. Possible mediators include insulin, free fatty acids, increased bio-availability of steroid hormones and inflammation. It is important to gain better understanding of the relationship between these diseases as new insights may provide new opportunities for cancer prevent

APA, Harvard, Vancouver, ISO, and other styles

9

Tam, Teresa. "The effects of Cree anti-diabetic natural health products on drug metabolism and cardiomyocytes." Thesis, University of Ottawa (Canada), 2009. http://hdl.handle.net/10393/28230.

Full text

Abstract:

Seventeen Cree anti-diabetic medicinal plant were investigated for their capacity to cause adverse effects when used as alternative or complementary medicine. Two aspects of safety were studied using their extracts: the ability to affect the contraction rate of neonatal rat cardiomyocytes in vitro to determine if the plants can influence the human heart rate, and the ability to interfere with drug metabolism by inhibiting the cytochrome P450 enzymes in vitro. The results suggest that several Cree plants may cause a harmful effect through different mechanisms. The extracts ofW2, W4, W5, and W9

APA, Harvard, Vancouver, ISO, and other styles

10

Gedawy, Ahmed Abou Bakr Gaber. "Innovative platforms for oral microencapsulation formulation and drug analytical techniques for anti-diabetics." Thesis, Curtin University, 2020. http://hdl.handle.net/20.500.11937/81966.

Full text

Abstract:

This thesis is divided into two main sections. The first section is about developing of silicon-based pharmaceutical platform that was used to encapsulate an anti-diabetic agent (metformin). These developed microcapsules were then characterised in terms of drug content, encapsulation efficiency, flow properties and microscopical examination. The second section is about development and validation of a new HPLC analytical method for the detection and quantification of metformin and two other anti-diabetic agents that belong to sulfonylureas.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Anti diabetic drugs"

1

Yŏm, Yŏng-il. Chŏnsachʻe pʻŭropʻail ŭl iyong han hang tangnyo chagyong kijŏn kŏmjŭng yŏnʼgu =: Study of the action mechanism of anti-diabetic drugs by transcriptome profiling. Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Canadian Coordinating Office for Health Technology Assessment., ed. Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents. Canadian Coordinating Office for Health Technology Assessment, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Medicinal Plants: Promising Future for Health and New Drugs. Taylor & Francis Group, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kuroedov, Alexey. Role of protein kinase C[beta] inhibitors and glycogen synthase kinase-3 inhibitors, new anti-diabetic drugs, in preventing atherogenic transformation of monocytes and endothelial activation. 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Li, Jie Jack. Laughing Gas, Viagra, and Lipitor. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195300994.001.0001.

Full text

Abstract:

The stories behind drug discovery are fascinating, full of human and scientific interest. This is a book on the history of drug discovery that highlights the intellectual splendor of discoverers as well as the human frailty associated them. History is replete with examples of breakthrough medicines that have saved millions of lives. Ether as an anesthetic by Morton; penicillin as an antibiotic by Fleming; and insulin as an anti-diabetic by Banting are just a few examples. The discoverers of these medicines are doubtlessly benefactors to mankind--for instance, without penicillin, 75% of us prob

APA, Harvard, Vancouver, ISO, and other styles

8

Ghani, Usman. Alpha-Glucosidase Inhibitors: Promising Candicates for Anti-Diabetic Drug Discovery. Elsevier, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ghani, Usman. Alpha-Glucosidase Inhibitors: Clinically Promising Candidates for Anti-Diabetic Drug Discovery. Elsevier, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Jones, Roy W. Pharmacological treatment of dementia. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199644957.003.0038.

Full text

Abstract:

This chapter summarises the available clinical evidence for specific pharmacological treatments for dementia with a particular emphasis on practical considerations and realistic expectations of currently available anti-dementia drugs. It covers the treatment of both cognitive and non-cognitive symptoms. The search for specific treatments for dementia has inevitably concentrated on Alzheimer’s disease (AD), partly because it is the commonest cause of dementia and partly because scientific progress has provided more potential therapeutic targets for AD than other dementias. AD is treated with AC

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Anti diabetic drugs"

1

Falcomatà, B., Maurizio Battaglia Parodi, P. Iacono, G. Guarnaccia, and F. Bandello. "Use of Anti-Vascular Endothelial Growth Factor Drugs for Diabetic Macular Edema." In Surgical Retina. S. KARGER AG, 2012. http://dx.doi.org/10.1159/000338155.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rao, Madhushree M. V., Likith M, Gayathri D S, Ravikumar H, and Hariprasad T P N. "Bioinformatics Tools for the Discovery of Potential Anti-Diabetic Drugs from Lichens." In Computational Approaches in Biotechnology and Bioinformatics. CRC Press, 2024. http://dx.doi.org/10.1201/9781003354437-10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chen, Shyi-Ming, Yun-Hou Huang, Rung-Ching Chen, Szu-Wei Yang, and Tian-Wei Sheu. "Using Fuzzy Reasoning Techniques and the Domain Ontology for Anti-Diabetic Drugs Recommendation." In Intelligent Information and Database Systems. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28487-8_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Thangaraj, Parimelazhagan. "Anti-diabetic Activity." In Progress in Drug Research. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-26811-8_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Thangaraj, Parimelazhagan. "Evaluation of Anti-diabetic Property on Streptozotocin-Induced Diabetic Rats." In Progress in Drug Research. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-26811-8_24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Veni, T., T. Pushpanathan, and G. Vimala. "Plant Constituent as Anti-Cancer Drugs." In Drug Development for Cancer and Diabetes. Apple Academic Press, 2020. http://dx.doi.org/10.1201/9780429330490-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pal, Sarbani, and Manojit Pal. "Anti-diabetes Research in India: Contributions from Industrial Organizations." In Drug Discovery and Drug Development. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-8002-4_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mukerji, Geetha, and Denice S. Feig. "Advances in Oral Anti-Diabetes Drugs in Pregnancy." In A Practical Manual of Diabetes in Pregnancy. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119043805.ch15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Arch, Jonathan R. S. "Thermogenesis and Related Metabolic Targets in Anti-Diabetic Therapy." In Diabetes - Perspectives in Drug Therapy. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-17214-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mtewa, Andrew G., Duncan Sesaazi, Amanjotannu, and Serawit Deyno. "Essential Drug Properties and Stages in Anti-Cancer Drug Development." In Drug Development for Cancer and Diabetes. Apple Academic Press, 2020. http://dx.doi.org/10.1201/9780429330490-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anti diabetic drugs"

1

Alkawari, Fatima, Wigdan Ali, Fatiha Benslimane, and Huseyin Yalcin. "Investigating the Cardiac effects of New Generation Anti-Diabetic Drug Empagliflozin using Zebrafish Embryo Model." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0211.

Full text

Abstract:

Type 2 diabetes mellitus (T2DM) affects >16% of adults in Qatar. Newly emerging class of antidiabetic drugs focused on SGLT inhibition were observed to reduce CVDs risks in diabetic patients. Up to date, the mechanism contributing to the CV benefits remains unrevealed. Zebrafish embryos were treated with Aristolochic Acid to induce heart failure then treated with Empagliflozin to determine its beneficial effect. Furthermore the expression of SGLT1 & 2 were determined in the hearts of zebrafish. SGLT2 was expressed more then SGLT1 in the heart and whole embryo. Empa significantly improve

APA, Harvard, Vancouver, ISO, and other styles

2

Chen, Rung-Ching, Cho-Tsan Bau, and Yun-Hou Huang. "Development of anti-diabetic drugs ontology for guideline-based clinical drugs recommend system using OWL and SWRL." In 2010 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE). IEEE, 2010. http://dx.doi.org/10.1109/fuzzy.2010.5584139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Mujahid, A., I. Haq, T. Hussain, S. Z. Bajwa, and A. Afzal. "P2BM.6 - Tailoring Molecular Imprinted Polymers as Biomimetic Recognition Coatings for Anti-Diabetic Drugs." In 17th International Meeting on Chemical Sensors - IMCS 2018. AMA Service GmbH, Von-Münchhausen-Str. 49, 31515 Wunstorf, Germany, 2018. http://dx.doi.org/10.5162/imcs2018/p2bm.6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Contreras, U., N. Ornelas-Soto, M. A. Meneses-Nava, O. Barbosa-García, P. L. López-de-Alba, and L. López-Martínez. "Rapid screening for quality control and adulteration in anti-diabetic drugs: quantitative and qualitative analysis by LIBS." In Applied Industrial Optics: Spectroscopy, Imaging and Metrology. OSA, 2010. http://dx.doi.org/10.1364/aio.2010.amc3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Loisay, L., S. Bouagga, A. Antoniadis, T. Hügle, and J. Geurts. "POS0794 ANTI-DIABETIC DRUGS TARGET SUBCHONDRAL MARROW ADIPOSE TISSUE METABOLISM IN A PRECLINICAL MODEL OF KNEE OSTEOARTHRITIS." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.6122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nishat, Zurwa, Tara Pellegrino, and Robert Steer. "Outcomes in Type II Diabetes Patients through the Covid 19 Pandemic A Retrospective Chart Review." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.54_2023.

Full text

Abstract:

Context: The COVID-19 pandemic provided a unique opportunity for urgent expansion of telemedicine services as providers continued to supply longitudinal care to patients. Patients with type II diabetes were vulnerable to serious infection with COVID-19 as well as disruption in management of their chronic disease. Objective: To delineate the outcomes in type II diabetes patients through the COVID-19 pandemic by a retrospective chart review in which disease management was evaluated through HbA1c levels and BMI. Methods: This retrospective chart review included adult T2DM patients receiving care

APA, Harvard, Vancouver, ISO, and other styles

7

Carvalho, Ana Cláudia Pires, Fernanda Rezende Dias, Luisa Crevelin Costa, and Natália de Castro Fim Nakao. "Myopathy following statin use." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.512.

Full text

Abstract:

Introduction: Myopathies can be caused by various drugs, including statins and corticosteroids, and can be toxic or inflammatory, one example being necrotizing myositis triggered by statins. Objectives: Describe the case of a patient with weakness after statin use. Design and setting: Case report Methods: Analysis of medical record, photographic record of the diagnostic methods and literature review. Case description: 69-year-old female, obese, hypertensive, diabetic, dyslipidemic and hypothyroid, taking atorvastatin since 2017, referred by endocrinology for generalized myalgia in 2019, with i

APA, Harvard, Vancouver, ISO, and other styles

8

Jakhotia, Sneha, Branislav Nastasijević, Gordana Joksić, Sreenivasa Reddy, and G. Bhanuprakash Reddy. "Gentiana lutea AND DIABETIC COMPLICATIONS." In 8th Workshop Food and Drug Safety and Qualit. Vinča Institute of Nuclear Sciences - National Institute of the Republic of Serbia, 2024. http://dx.doi.org/10.46793/8fdsq.ild1sj.

Full text

Abstract:

Chronic hyperglycemia in diabetes leads to macro and microvascular complications. An increase in the aldose reductase (ALR2) activity, accumulation of sorbitol, accumulation of advanced glycation end-products (AGEs), and inflammation lead to cellular damage, ultimately resulting in complications. ALR2 inhibition has been a consideration to treat/manage diabetic complications, but most of the ALR2 inhibitors are not free of side effects. As a part of our work to find better ALR2 inhibitors, we found that extracts of Gentiana lutea exhibited ALR2 inhibitory potential in vitro. We have also disco

APA, Harvard, Vancouver, ISO, and other styles

9

Falabella, Petra, and Željka Večerić-Haler. "Arginine Vasopressin Resistance (AVP-R)." In Socratic Lectures 11. University of Lubljana Press, 2024. http://dx.doi.org/10.55295/psl.11.2024.1.

Full text

Abstract:

Arginine vasopressin resistance (AVP-R) previously known as nephrogenic diabetes insipidus is a rare disorder characterised with large fluid output due to resistance to arginine vasopressin in kidneys. It can be caused by different etiologies, including hereditary causes. In diagnosis we must determine the reason for polyuria (vasopressin deficiency, resistance, or primary polydipsia). Treatment is mostly symptomatic with adequate water consumption in combination with low-salt and low-protein diet. The main drugs used to treat AVP-R are thiazide diuretics, non-steroidal anti-inflammatory drugs

APA, Harvard, Vancouver, ISO, and other styles

10

Christopher, Devasahayam Jesudas, Deva Jedidiah, Barney Isaac, Binu Mathew, and Blessed Winston. "Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients - Diabetic vs Non-Diabetic groups." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2999.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Anti diabetic drugs"

1

Jin, Dachuan, Gao Peng, Shunqin Jin, Tao Zhou, Baoqiang Guo, and Guangming Li. Comparison of therapeutic effects of anti-diabetic drugs on non-alcoholic fatty liver disease patients without diabetes: A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0014.

Full text

Abstract:

Review question / Objective: To evaluate the efficacy of different anti-diabetic drugs in the treatment of non-diabetic non-alcoholic disease by network meta-analysis, and find the best intervention. Condition being studied: Non-alcoholic fatty liver disease (NAFLD) refers to the disease in which the liver fat content exceeds 5%, and excludes the secondary causes of alcohol, infection, drugs or other specific metabolic diseases. As a spectrum of disorders, it includes hepatocyte steatosis and steatohepatitis at the initial stage, liver fibrosis at the later stage, cirrhosis at the final stage,

APA, Harvard, Vancouver, ISO, and other styles

2

Jiang, Yang, Wei He, and Shi-xin Qi. Evaluating the efficacy of subthreshold micropulse laser combined with anti-VEGF drugs in the treatment of diabetic macular edema: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Piao, Tianhua, Hongyang Ma, and Rui Wang. Comparison Between Ozurdex and TA as An Adjunct Drug Combined with Intravitreal anti-VEGF Treatment for Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!